The independent source for health policy research, polling, and news.
3,761-3,780 of 113,016 results
The lawsuit was brought against the FDA after the agency declared an end to the shortage that allowed pharmacies to sell compound versions of the popular weight loss drugs, but Eli Lilly said it cannot rely on the FDA to protect its interests. Other news is on the surge of GLP-1 use; insurance coverage of obesity medicine; and more.
Today's early morning highlights from the major news organizations.
Each week, KFF Health News compiles a selection of the latest health research and news.
Also in the news: Experts in Texas make a case for mental health funds; New Yorkers will receive paid leave for prenatal care; Colorado explores psychedelic therapy; and more.
The Wall Street Journal reports how UnitedHealth provided lists of potential, often obscure diagnoses to its doctors and forced them to weigh in on them for each Medicare Advantage patient, in order to capitalize on the government system that pays private insurers based on how sick doctors say a patient is.
The tool developed by British researchers examines patient data to calculate risks for people who might develop the condition. Meanwhile, Stat reports on a study of pulse oximeters, which are currently not calibrated to work as well for people with darker skin. Other news includes antibiotic resistance, GLP-1 withdrawal, and more.
The outbreak took place between 2022 and 2023 and was the first such outbreak to take place in an industrial setting. In other news: broccoli recalls; vapes are still being shipped through the mail, even though it's illegal; and more.
Some nursing homes are preparing for the new staffing regulations from the Centers for Medicare and Medicaid Services slated to take effect in 2025. Others are holding back, waiting to see if the rule is likely to survive the Trump administration.
Meanwhile, drugmakers are expected to raise prices on over 250 medications in the new year; rules for hospital price transparency are updated; and more.
The agency says it is looking for red flags, but the risk to the public still remains low. Meanwhile, samples collected from a Louisiana patient with a severe case of bird flu showed worrying mutations. Other outbreak news includes surges in covid and norovirus.
Editorial writers discuss these public health topics.
Today's early morning highlights from the major news organizations.
Opinion writers discuss these public health issues.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on syphilis, medical sexism, euthanasia, the year's best public health books, and more.
The cyberattack happened earlier this year, the company disclosed. Other industry news comes from CVS, Gilead, Ionis, and more.
Meanwhile, synthetic gel aids in recovery after spinal surgery; Pittsburgh researchers create helper robots for people with ALS; a study finds nerve stimulation is effective against treatment-resistant depression; and more.
According to updated FDA guidelines, a product qualifies for a "healthy" claim on food labels if it has certain amounts of at least one of the food groups: dairy, grains, fruits, vegetables and protein. Other news examines: veteran suicides, painkillers, product recalls, and more.
A lawsuit forced the FDA to reassess its ruling on the availability of tirzepatide, the active ingredient in the popular drugs Mounjaro and Zepbound from Eli Lilly. As a result, the agency also told pharmacies and online companies selling off-brand copies of those drugs that they must come off the market.
Lawmakers must now come up with a Plan C after a version of a stopgap spending bill – that had the seal of approval of incoming President Donald Trump after he scuttled the first version of a deal – was voted down 174-235 Thursday night. The deadline toward a government shutdown is tonight.
ProPublica reports that the CDC and NIH have underdelivered on pledges to measure maternal deaths and long-term injuries in states with abortion bans. Texas' decision not to review such deaths in the first two years of its state's near-total ban is being challenged by some House members. Meanwhile, a new report finds that hospitals are providing minimal guidance to doctors.
© 2026 KFF